HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideya Onishi Selected Research

ONO-7579

1/2018The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideya Onishi Research Topics

Disease

54Neoplasms (Cancer)
07/2022 - 12/2002
13Pancreatic Neoplasms (Pancreatic Cancer)
08/2021 - 12/2009
10Hypoxia (Hypoxemia)
05/2022 - 06/2011
9Carcinoma (Carcinomatosis)
07/2022 - 10/2003
8Adenocarcinoma
08/2021 - 12/2010
8Breast Neoplasms (Breast Cancer)
07/2018 - 11/2003
7Neoplasm Metastasis (Metastasis)
09/2018 - 12/2003
3Inflammation (Inflammations)
05/2022 - 12/2009
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 03/2013
3Colonic Neoplasms (Colon Cancer)
12/2010 - 12/2009
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2021 - 03/2013
2Ascites
07/2021 - 02/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 11/2017
2Fibrosis (Cirrhosis)
01/2021 - 01/2020
2Gallbladder Neoplasms (Gallbladder Cancer)
01/2018 - 05/2017
2Cholangiocarcinoma
01/2018 - 06/2012
2Stomach Neoplasms (Stomach Cancer)
10/2017 - 07/2011
2Carcinogenesis
09/2013 - 10/2011
2Hepatocellular Carcinoma (Hepatoma)
04/2013 - 07/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2012 - 12/2003
2Melanoma (Melanoma, Malignant)
11/2011 - 12/2003
2Colorectal Neoplasms (Colorectal Cancer)
07/2011 - 12/2003
2Malignant Pleural Effusion
11/2003 - 05/2002
1Ovarian Neoplasms (Ovarian Cancer)
07/2021
1Cholelithiasis
09/2018
1Triple Negative Breast Neoplasms
07/2018
1Cysts
01/2016
1Postoperative Pain
06/2015

Drug/Important Bio-Agent (IBA)

8GemcitabineFDA Link
01/2021 - 07/2011
7AntigensIBA
05/2022 - 05/2002
7Small Interfering RNA (siRNA)IBA
03/2019 - 07/2011
6Peptides (Polypeptides)IBA
07/2022 - 07/2011
6VaccinesIBA
07/2022 - 12/2003
6Biological ProductsIBA
09/2021 - 03/2013
6Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2021 - 03/2013
6TropomyosinIBA
08/2021 - 03/2013
6Phosphotransferases (Kinase)IBA
08/2021 - 03/2013
6Proteins (Proteins, Gene)FDA Link
03/2019 - 12/2003
5CytokinesIBA
05/2022 - 07/2011
5LigandsIBA
08/2014 - 06/2011
5Interleukin-4 (Interleukin 4)IBA
06/2012 - 04/2004
4Interleukin-12 (IL 12)IBA
06/2013 - 12/2002
4cyclopamineIBA
06/2013 - 12/2011
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2012 - 04/2004
3Neoplasm Antigens (Tumor Antigens)IBA
07/2022 - 12/2002
3Immunoglobulins (Immunoglobulin)IBA
08/2018 - 02/2016
3Carrier Proteins (Binding Protein)IBA
08/2018 - 02/2016
3Epithelial Cell Adhesion MoleculeIBA
07/2018 - 08/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 06/2010
3Matrix Metalloproteinases (MMPs)IBA
08/2016 - 09/2013
3NF-kappa B (NF-kB)IBA
05/2010 - 12/2004
2Immune Checkpoint InhibitorsIBA
07/2022 - 10/2019
2EpitopesIBA
08/2021 - 07/2021
2Leukocyte Common Antigens (CD45 Antigen)IBA
03/2019 - 12/2017
2catumaxomabIBA
07/2018 - 08/2014
2Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 07/2011
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 11/2012
2micaIBA
08/2014 - 07/2011
2Messenger RNA (mRNA)IBA
08/2014 - 06/2010
2Oxygen (Dioxygen)IBA
06/2013 - 06/2011
2InterferonsIBA
06/2012 - 07/2011
2Monoclonal AntibodiesIBA
06/2012 - 11/2003
2matrigelIBA
02/2011 - 12/2009
2Transforming Growth Factor beta (TGF-beta)IBA
05/2010 - 10/2003
2PicibanilIBA
11/2003 - 09/2003
1NivolumabIBA
07/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022
1Fibronectins (Fibronectin)IBA
01/2022
1AminopeptidasesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Cancer VaccinesIBA
08/2021
1TrypsinIBA
06/2021
1A-factor (Streptomyces)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
07/2019
1MicroRNAs (MicroRNA)IBA
07/2019
1Metronidazole (Metric)FDA LinkGeneric
01/2018
1ONO-7579IBA
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1Vascular Endothelial Growth Factor CIBA
05/2017
1Vascular Endothelial Growth Factor DIBA
05/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017
1Neutralizing AntibodiesIBA
12/2016
1polysaccharide-KIBA
08/2016
1DNA (Deoxyribonucleic Acid)IBA
02/2016
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2016
1Leukemia Inhibitory FactorIBA
02/2016
1Alkaline PhosphataseIBA
02/2016
1Conditioned Culture MediaIBA
02/2016
1Octamer Transcription Factor-3 (Oct 4 Transcription Factor)IBA
02/2016
1Antisense OligonucleotidesIBA
01/2016
1AldehydesIBA
08/2014
1PolyaminesIBA
06/2014

Therapy/Procedure

21Immunotherapy
05/2022 - 12/2002
18Therapeutics
07/2022 - 11/2003
10Drug Therapy (Chemotherapy)
01/2020 - 11/2003
2Gastrectomy
10/2017 - 01/2016
2Intravenous Injections
11/2005 - 11/2003
1Cholecystectomy
09/2018
1Lymph Node Excision (Lymph Node Dissection)
01/2016
1Length of Stay
06/2015